Walter G. Chambliss
About
In The Last Decade
Walter G. Chambliss
17 papers receiving 339 citations
Peers
Comparison fields: 5 of 103
- Pharmaceutical Science 84
- Molecular Biology 68
- Pharmacology 61
- Oncology 44
- Pharmacology 44
Countries citing papers authored by Walter G. Chambliss
This map shows the geographic impact of Walter G. Chambliss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter G. Chambliss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter G. Chambliss more than expected).
Fields of papers citing papers by Walter G. Chambliss
This network shows the impact of papers produced by Walter G. Chambliss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter G. Chambliss. The network helps show where Walter G. Chambliss may publish in the future.
Co-authorship network of co-authors of Walter G. Chambliss
This figure shows the co-authorship network connecting the top 25 collaborators of Walter G. Chambliss. A scholar is included among the top collaborators of Walter G. Chambliss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter G. Chambliss. Walter G. Chambliss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 26 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 1 | |
| 6 | 44 | |
| 7 | 2 | |
| 8 | 30 | |
| 9 | 12 | |
| 10 | Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. | 34 |
| 11 | Dietary supplements: important concerns for the clinician. | 3 |
| 12 | 9 | |
| 13 | 0 | |
| 14 | 113 | |
| 15 | 33 | |
| 16 | 17 | |
| 17 | 8 | |
| 18 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.